HealthCor Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-283,520
| Closed | -$18.4M | – | 51 |
|
|
2019
Q4 | $18.4M | Sell |
283,520
-199,410
| -41% | -$13M | 0.66% | 41 |
|
|
2019
Q3 | $30.6M | Sell |
482,930
-280,370
| -37% | -$17.8M | 1.16% | 32 |
|
|
2019
Q2 | $51.6M | Buy |
763,300
+139,810
| +22% | +$9.45M | 2% | 22 |
|
|
2019
Q1 | $40.5M | Buy |
+623,490
| New | +$40.5M | 1.64% | 24 |
|
|
2018
Q4 | – | Sell |
-132,870
| Closed | -$10.3M | – | 41 |
|
|
2018
Q3 | $10.3M | Buy |
+132,870
| New | +$10.3M | 0.34% | 37 |
|
|
2018
Q2 | – | Sell |
-656,690
| Closed | -$49.5M | – | 51 |
|
|
2018
Q1 | $49.5M | Buy |
+656,690
| New | +$49.5M | 1.68% | 23 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 41 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 45 |
|
|
2016
Q3 | – | Sell |
-270,680
| Closed | -$22.6M | – | 40 |
|
|
2016
Q2 | $22.6M | Buy |
+270,680
| New | +$22.6M | 1.23% | 25 |
|
|
2015
Q2 | – | Sell |
-69,200
| Closed | -$6.79M | – | 57 |
|
|
2015
Q1 | $6.79M | Sell |
69,200
-1,180,800
| -94% | -$116M | 0.32% | 40 |
|
|
2014
Q4 | $118M | Buy |
+1,250,000
| New | +$118M | 6.57% | 2 |
|
|
2014
Q3 | – | Sell |
-447,600
| Closed | -$37.1M | – | 45 |
|
|
2014
Q2 | $37.1M | Sell |
447,600
-412,892
| -48% | -$34.2M | 1.86% | 23 |
|
|
2014
Q1 | $61M | Buy |
860,492
+685,492
| +392% | +$48.6M | 3.67% | 10 |
|
|
2013
Q4 | $13.1M | Sell |
175,000
-1,325,000
| -88% | -$99.5M | 0.8% | 31 |
|
|
2013
Q3 | $94.3M | Sell |
1,500,000
-600,000
| -29% | -$37.7M | 5.05% | 2 |
|
|
2013
Q2 | $108M | Buy |
+2,100,000
| New | +$108M | 6.51% | 2 |
|